Research Analysts’ Upgrades for December 15th (A, AMGN, BMY, CRL, DG, FAST, GTM, HLT, IMAX, MAR)

Research Analysts’ upgrades for Monday, December 15th:

Agilent Technologies (NYSE:A) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. The firm currently has $165.00 target price on the stock.

Amgen (NASDAQ:AMGN) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $61.00 price target on the stock, up from their previous price target of $52.00.

Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $225.00 price target on the stock.

Dollar General (NYSE:DG) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $166.00 price target on the stock, up from their previous price target of $128.00.

Fastenal (NASDAQ:FAST) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. They currently have $52.00 target price on the stock, up from their previous target price of $45.00.

ZoomInfo Technologies (NASDAQ:GTM) was upgraded by analysts at KeyCorp from an underweight rating to a sector weight rating.

Hilton Worldwide (NYSE:HLT) was upgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a buy rating. The firm currently has $317.00 price target on the stock, up from their previous price target of $285.00.

IMAX (NYSE:IMAX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $47.00 target price on the stock, up from their previous target price of $32.00.

Marriott International (NASDAQ:MAR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a buy rating. They currently have $345.00 target price on the stock, up from their previous target price of $288.00.

Milestone Pharmaceuticals (NASDAQ:MIST) was upgraded by analysts at TD Cowen from a hold rating to a buy rating. The firm currently has $8.00 target price on the stock.

McCormick & Company, Incorporated (NYSE:MKC) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating. Deutsche Bank Aktiengesellschaft currently has $75.00 price target on the stock.

Mettler-Toledo International (NYSE:MTD) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $1,600.00 target price on the stock.

Nordson (NASDAQ:NDSN) was upgraded by analysts at Vertical Research from a hold rating to a buy rating. Vertical Research currently has $270.00 price target on the stock.

Northrop Grumman (NYSE:NOC) was upgraded by analysts at Alembic Global Advisors from a neutral rating to an overweight rating. The firm currently has $662.00 price target on the stock.

Neste Oyj (OTCMKTS:NTOIF) was upgraded by analysts at Berenberg Bank from a hold rating to a buy rating.

Park Dental Partners (NASDAQ:PARK) was upgraded by analysts at Wall Street Zen to a hold rating.

Schrodinger (NASDAQ:SDGR) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $24.00 target price on the stock.

Trane Technologies (NYSE:TT) was upgraded by analysts at KeyCorp from a sector weight rating to an overweight rating. They currently have $500.00 target price on the stock.